$0.1859
0.0148[8.65%]
At close: May 3
$0.1859
0[0.00%]
After Hours: 7:49PM EDT
Tonix Pharmaceuticals
(NASDAQ:TNXP)Tonix Pharmaceuticals Stock (NASDAQ:TNXP), Analyst Ratings, Price Targets, Predictions
Tonix Pharmaceuticals Holding Corp has a consensus price target of $3.87, established from looking at the 7 latest analyst ratings. The last 3 analyst ratings were released from Dawson James, Alliance Global Partners, and Alliance Global Partners on February 28, 2024, August 1, 2023, and June 2, 2023. With an average price target of $9.67 between Dawson James, Alliance Global Partners, and Alliance Global Partners, there's an implied 5099.93% upside for Tonix Pharmaceuticals Holding Corp from these 3 analyst ratings.
Analyst Firms Making Recommendations1
Dawson James
Alliance Global Partners
Noble Capital Markets
1calculated from analyst ratings published within the last 3 years
Analyst Ratings for Tonix Pharmaceuticals
date | ticker | Buy Now | Company | Current price | Upside/Downside | Analyst Firm | Analyst & % Accurate | Price Target Change | Rating Change | Previous / Current Rating | Get Alert |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 02/28/2024 | TNXP | Buy Now | Tonix Pharmaceuticals | $0.19 | 1513.77% | Dawson James | Jason Kolbert | → $3 | Initiates | → Buy | Get Alert |
| 08/01/2023 | TNXP | Buy Now | Tonix Pharmaceuticals | $0.19 | 4203.39% | Alliance Global Partners | James Molloy | $18 → $8 | Maintains | Buy | Get Alert |
| 06/02/2023 | TNXP | Buy Now | Tonix Pharmaceuticals | $0.19 | 9582.63% | Alliance Global Partners | James Molloy | $6.5 → $18 | Maintains | Buy | Get Alert |
| 01/12/2023 | TNXP | Buy Now | Tonix Pharmaceuticals | $0.19 | 3396.5% | Alliance Global Partners | James Molloy | → $40.62 | Reiterates | → Buy | Get Alert |
| 04/18/2022 | TNXP | Buy Now | Tonix Pharmaceuticals | $0.19 | 222.75% | Noble Capital Markets | Robert LeBoyer | → $120 | Initiates | → Outperform | Get Alert |
| 08/31/2021 | TNXP | Buy Now | Tonix Pharmaceuticals | $0.19 | 1513.77% | Alliance Global Partners | James Molloy | $2 → $3 | Maintains | Buy | Get Alert |
| 08/11/2021 | TNXP | Buy Now | Tonix Pharmaceuticals | $0.19 | 975.85% | Alliance Global Partners | James Molloy | $4 → $2 | Maintains | Buy | Get Alert |
FAQ
What is the target price for Tonix Pharmaceuticals (TNXP)?
The latest price target for Tonix Pharmaceuticals (NASDAQ: TNXP) was reported by Dawson James on February 28, 2024. The analyst firm set a price target for $3.00 expecting TNXP to rise to within 12 months (a possible 1513.77% upside). 3 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Tonix Pharmaceuticals (TNXP)?
The latest analyst rating for Tonix Pharmaceuticals (NASDAQ: TNXP) was provided by Dawson James, and Tonix Pharmaceuticals initiated their buy rating.
When was the last upgrade for Tonix Pharmaceuticals (TNXP)?
There is no last upgrade for Tonix Pharmaceuticals.
When was the last downgrade for Tonix Pharmaceuticals (TNXP)?
There is no last downgrade for Tonix Pharmaceuticals.
When is the next analyst rating going to be posted or updated for Tonix Pharmaceuticals (TNXP)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Tonix Pharmaceuticals, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Tonix Pharmaceuticals was filed on February 28, 2024 so you should expect the next rating to be made available sometime around February 28, 2025.
Is the Analyst Rating Tonix Pharmaceuticals (TNXP) correct?
While ratings are subjective and will change, the latest Tonix Pharmaceuticals (TNXP) rating was a initiated with a price target of $0.00 to $3.00. The current price Tonix Pharmaceuticals (TNXP) is trading at is $0.19, which is within the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.